These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3485463)

  • 21. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS; Abell CW; Gessner W; Brossi A
    FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
    Caliguri EJ; Johannessen JN
    Brain Res; 1991 May; 548(1-2):94-9. PubMed ID: 1714336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
    Snape BM; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
    J Pharm Pharmacol; 1988 Sep; 40(9):620-6. PubMed ID: 2907028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo release of dopamine by perfusion of 1-methyl-4-phenylpyridinium ion in the striatum with a microdialysis technique.
    Obata T; Yamanaka Y; Chiueh CC
    Jpn J Pharmacol; 1992 Nov; 60(3):311-3. PubMed ID: 1491520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
    Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Mytilineou C; Cohen G
    J Neurochem; 1985 Dec; 45(6):1951-3. PubMed ID: 3932598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G; Nwanze E; Luthman J; Sundström E
    Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropharmacological manipulations with MPTP.
    Barnes NJ; Bradbury AJ; Costall B; Domeney AM; Kelly ME; Naylor RJ
    J Neural Transm Suppl; 1986; 20():47-63. PubMed ID: 3091761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices.
    Flint RS; Murphy JM; McBride WJ
    Neurochem Res; 1985 Apr; 10(4):515-27. PubMed ID: 2860579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.
    Booth RG; Castagnoli N; Rollema H
    Neurosci Lett; 1989 May; 100(1-3):306-12. PubMed ID: 2788253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl.
    Fuller RW; Hemrick-Luecke SK
    Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM; Arora PK; Iacofano LA; Harik SI
    Eur J Pharmacol; 1986 May; 124(1-2):171-4. PubMed ID: 3487462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
    Sershen H; Mason MF; Debler EA; Lajtha A
    Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo.
    Miyake H; Chiueh CC
    Eur J Pharmacol; 1989 Jul; 166(1):49-55. PubMed ID: 2478372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical investigations in vitro with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in preparations of rat brain.
    Markstein R; Lahaye D
    Eur J Pharmacol; 1984 Nov; 106(2):301-11. PubMed ID: 6335691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.